SCHEMBL20221297

SCHEMBL20221297

CC(C)(O)C(C)(C)C(=O)NCc1nc2ccc(C#Cc3ccc4nc(CNC(=O)C(C)(C)C(C)(C)O)[nH]c4c3)cc2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ CACNA1H O95180 2/20 0.41
▸ CACNA1G O43497 1/20 0.41
▸ TSHR P16473 2/20 0.40
▸ MAPK10 P53779 2/20 0.40
▸ CACNA1B Q00975 1/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ GSK3B P49841 2/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ CSNK1A1 P48729 1/20 0.38
▸ CSNK1D P48730 1/20 0.38
▸ CSNK1G2 P78368 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.36
▸ KLK1 P06870 1/20 0.36
▸ KLK5 Q9Y337 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20054596 0.93 SMN1; SMN2 (0.43) SMN1; SMN2CACNA1HCACNA1GTSHRMAPK10
SCHEMBL16444172 0.75 SMN1; SMN2 (0.55) SMN1; SMN2CACNA1HCACNA1GTSHRMAPK10
SCHEMBL15584680 0.75 CACNA1H (0.48) SMN1; SMN2CACNA1HCACNA1GTSHRMAPK10
SCHEMBL15584675 0.74 CACNA1H (0.47) SMN1; SMN2CACNA1HCACNA1GTSHRMAPK10
SCHEMBL12066792 0.73 CACNA1H (0.50) SMN1; SMN2CACNA1HCACNA1GTSHRMAPK10
SCHEMBL16882383 0.73 CACNA1H (0.50) SMN1; SMN2CACNA1HCACNA1BKMT2AGSK3B
SCHEMBL16444723 0.72 SMN1; SMN2 (0.56) SMN1; SMN2CACNA1HCACNA1GTSHRMAPK10
SCHEMBL19388574 0.71 SCN10A (0.35) GSK3BCSNK1A1CSNK1DCSNK1G2ALDH1A1
SCHEMBL15116840 0.71 SCN10A (0.35) GSK3BCSNK1A1CSNK1DCSNK1G2ALDH1A1
SCHEMBL11296984 0.71 SMN1; SMN2 (0.76) SMN1; SMN2KMT2APOLBALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019196-B1 COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-06-06 — — EP disclosed
Send feedback